Marathon Trading Investment Management’s Gilead Sciences GILD Stock Holding History

Marathon Trading Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,600	Closed	-$579K	–	360
2020 Q3	$607K	Buy	+9,600	New	+$666K	0.05%	175
2019 Q4	–	Sell	-4,300	Closed	-$273K	–	195
2019 Q3	$273K	Buy	+4,300	New	+$281K	0.05%	156
2018 Q2	–	Sell	-2,800	Closed	-$211K	–	201
2018 Q1	$211K	Buy	+2,800	New	+$223K	0.02%	152
2015 Q4	–	Sell	-2,400	Closed	-$236K	–	254
2015 Q3	$236K	Sell	2,400 -14,600	-86%	-$1.62M	0.01%	275
2015 Q2	$1.99M	Buy	17,000 +9,600	+130%	+$1.05M	0.08%	159
2015 Q1	$726K	Sell	7,400 -11,800	-61%	-$1.2M	0.04%	294
2014 Q4	$1.81M	Buy	19,200 +2,400	+14%	+$248K	0.03%	273
2014 Q3	$1.79M	Buy	16,800 +8,000	+91%	+$783K	0.05%	129
2014 Q2	$730K	Buy	8,800 +1,500	+21%	+$117K	0.02%	179
2014 Q1	$517K	Buy	+7,300	New	+$573K	0.02%	169

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marathon Trading Investment Management's GILD Position: Q4 2020 in Review

Marathon Trading Investment Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 9,600 shares — an estimated $579K sold.

Marathon Trading Investment Management first reported a position in GILD in Q1 2014 and held it in 10 quarters. The position peaked at $1.99M in Q2 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Marathon Trading Investment Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
Marathon Trading Investment Management sold 9,600 Gilead Sciences shares in Q4 2020, an estimated $579K.
Marathon Trading Investment Management first reported a position in Gilead Sciences in Q1 2014 and held it in 10 quarters.
Marathon Trading Investment Management's Gilead Sciences position peaked at $1.99M in Q2 2015.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Marathon Trading Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.